Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review

被引：8

作者：

Nepal, Gaurav ^{[1
]}

Khurana, Mahika ^{[2
]}

Bucheli, Domenica Herrera ^{[3
]}

Bhandari, Siddhartha ^{[1
]}

Joshi, Utsav ^{[4
]}

Bhagat, Riwaj ^{[5
]}

Rehrig, Jessica Holly ^{[6
]}

Pudasainee, Prasun ^{[7
]}

Shing, Yow Ka ^{[8
]}

Ortiz, Juan Fernando ^{[9
]}

Ojha, Rajeev ^{[10
]}

Gajurel, Bikram Prasad ^{[10
]}

Quinonez, Jonathan ^{[11
,12
]}

Ruxmohan, Samir ^{[11
]}

Albert, Trevine ^{[12
]}

Licata, Steven ^{[12
]}

Stien, Joel ^{[12
]}

机构：

[1] Tribhuvan Univ, Dept Internal Med, Inst Med, Kathmandu 44600, Nepal

[2] Berkeley Publ Hlth Div, Dept Publ Hlth, Berkeley, CA 94704 USA

[3] Univ Int Ecuador, Dept Med, Loja 110150, Ecuador

[4] Rochester Gen Hosp, Dept Internal Med, Rochester, NY 14621 USA

[5] Boston Univ, Dept Neurol, Med Ctr, Boston, MA 02118 USA

[6] North Shore Univ Hosp, Dept Neurol, Manhasset, NY 11030 USA

[7] AMITA Hlth St Francis Hosp, Dept Internal Med, Evanston, IL 60202 USA

[8] Natl Univ Singapore Hosp, Dept Internal Med, Singapore 119074, Singapore

[9] Calif Inst Behav Neurosci & Psychol, Dept Neurol, Fairfield, CA 94534 USA

[10] Tribhuvan Univ Teaching Hosp, Dept Neurol, Kathmandu 44600, Nepal

[11] Larkin Community Hosp, Dept Neurol, South Miami, FL 33143 USA

[12] Larkin Community Hosp, Dept Osteopath Neuromuscular Med, Miami, FL 33143 USA

来源：

NEUROLOGY INTERNATIONAL | 2022年 / 14卷 / 01期

关键词：

ibrutinib; BTK; Bruton tyrosine kinase inhibitor; PCNSL; primary central nervous system lymphoma; lymphoma; CNS LYMPHOMA; RADIOTHERAPY; MONOTHERAPY; OUTCOMES;

D O I：

10.3390/neurolint14010009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Primary Central Nervous System Lymphoma (PCNSL) is a rare variant of Non-Hodgkin Lymphoma (NHL) representing 1-2% of all NHL cases. PCNSL is defined as a lymphoma that occurs in the brain, spinal cord, leptomeninges, or eyes. Efforts to treat PCNSL by traditional chemotherapy and radiotherapy have generally been unsuccessful as a significant proportion of patients have frequent relapses or are refractory to treatment. The prognosis of patients with Refractory or Relapsed (R/R) PCNSL is abysmal. The optimal treatment for R/R PCNSL is poorly defined as there are only a limited number of studies in this setting. Several studies have recently shown that ibrutinib, a Bruton tyrosine kinase (BTK) inhibitor, has promising results in the treatment of R/R PCNSL. However, these are preliminary studies with a limited sample size. In this systematic review, we explored and critically appraised the evidence about the efficacy of the novel agent ibrutinib in treating R/R PCNSL.

引用

页码：99 / 108

页数：10

共 50 条

[31] SALVAGE CHEMOTHERAPY WITH TEMOZOLOMIDE IN REFRACTORY OR RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Makino, Keishi
Nakamura, Hideo
Hide, Takuichiro
Kuratsu, Jun-ichi
NEURO-ONCOLOGY, 2009, 11 (06) : 916 - 916
[32] Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib
Cheng, Qiansong
Wang, Jing
Lv, Chenglan
Xu, Jingyan
ONCOTARGETS AND THERAPY, 2021, 14 : 3367 - 3372
[33] Primary Central Nervous System Lymphoma
Doucet, Stephane
Kumthekar, Priya
Raizer, Jeffrey
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 185 - 197
[34] Primary central nervous system lymphoma
Gloghini, Annunziata
Carbone, Antonino
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2015, 6 (01) : 2 - 3
[35] Primary Central Nervous System Lymphoma
Sinicrope, Kaylyn
Batchelor, Tracy
NEUROLOGIC CLINICS, 2018, 36 (03) : 517 - +
[36] Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma
Voloschin, Alfredo D.
Betensky, Rebecca
Wen, Patrick Y.
Hochberg, Fred
Batchelor, Tracy
JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (02) : 211 - 215
[37] Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma
Alfredo D. Voloschin
Rebecca Betensky
Patrick Y. Wen
Fred Hochberg
Tracy Batchelor
Journal of Neuro-Oncology, 2008, 86 : 211 - 215
[38] Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan
Fischer, L
Thiel, E
Klasen, HA
Kirchen, H
Jahnke, K
Korfel, A
NEUROLOGY, 2004, 62 (10) : 1885 - 1887
[39] Primary Central Nervous System Lymphoma
Dong Yan-Hong
Teng Zhen-Jie
Hu Ming
Wei Ci
Chen Ying-Min
Zhao Huan-Fen
Zhang Shu-Qian
Lyu Pei-Yuan
中华医学杂志英文版, 2016, 129 (05) : 609 - 611
[40] Primary central nervous system lymphoma
Batchelor, Tracy T.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 379 - 385

← 1 2 3 4 5 →